JFLB(002762)

Search documents
ST金比“易主”涨停:新东家真能力挽狂澜?
Huan Qiu Wang· 2025-06-12 07:38
Core Viewpoint - The stock price of *ST Jinbi surged to a limit up of 6.47 yuan per share following the announcement of a change in control, with Shanghai Yuancheng Chengwu Technology Co., Ltd. becoming the new controlling shareholder and Chen Keru as the actual controller [1]. Group 1: Control Change Details - On June 11, the current controlling shareholders Lin Haoliang and Lin Ruowen signed a share transfer agreement with Yuancheng Chengwu, transferring a total of 13.3% of the company's shares at a price of 7.34 yuan per share, amounting to approximately 346 million yuan [1]. - After the first transfer, Yuancheng Chengwu will hold 13.3% of the shares and the current shareholders will relinquish their voting rights, leading to a board majority for Yuancheng Chengwu [1]. - Upon completion of the second transfer, Yuancheng Chengwu will own 28% of the shares, with the previous shareholders continuing to forfeit their voting rights [1]. Group 2: Company Performance and Risks - Founded in 1996, *ST Jinbi specializes in the research, design, production, and sales of maternal and infant consumer products, managing brands such as "LABI BABY," "I LOVE BABY," and "BABY LABI" [4]. - The company reported a total profit of 70.77 million yuan and a net profit of 49.69 million yuan for the fiscal year 2024, but the net profit after excluding non-recurring gains and losses was -45.32 million yuan, with revenue below 300 million yuan [4]. - In Q1 of the current year, the company achieved revenue of 76.06 million yuan, a year-on-year increase of 74.85%, but the net profit after deductions was -253,030 yuan, indicating a shift from profit to loss [5].
复牌涨停!002762控制权拟变更
Zheng Quan Ri Bao Wang· 2025-06-12 03:01
Group 1 - The company *ST Jinbi (002762) has experienced a stock price surge, reaching a limit up at 6.47 yuan per share following the announcement of a change in control [1] - Shanghai Yuancheng Chengwu Technology Co., Ltd. will become the controlling shareholder, with Chen Keru as the actual controller of the company [1][2] - The share transfer agreement involves Lin Haoliang and Lin Ruowen transferring a combined 13.3% of the company's total shares to Yuancheng Chengwu at a price of 7.34 yuan per share, totaling approximately 346 million yuan [1][2] Group 2 - Following the first share transfer, Yuancheng Chengwu will hold 13.3% of the shares, and Lin Haoliang and Lin Ruowen will relinquish all voting rights for their remaining shares [2] - After the second share transfer, Yuancheng Chengwu will own 28% of the company, maintaining majority representation on the board [2] - *ST Jinbi, founded in 1996, is one of the early companies in China engaged in the research, design, production, sales, and service of maternal and infant products, operating well-known brands such as "LABI BABY" and "I LOVE BABY" [2] Group 3 - For the fiscal year 2024, the company reported a total profit of 70.77 million yuan and a net profit of 49.69 million yuan, but a net profit of -45.32 million yuan after deducting non-recurring gains and losses, triggering delisting risk warnings [3] - In Q1 of the current year, the company achieved revenue of 76.06 million yuan, a year-on-year increase of 74.85%, but reported a net loss of 2.53 million yuan after deductions, indicating a shift from profit to loss [3] - The new controlling shareholder, Yuancheng Chengwu, currently has no plans to inject assets into the company, which may lead to stock price volatility detached from fundamentals [3][4]
创始人夫妇拟转让部分股份 *ST金比或迎新实控人
Zheng Quan Shi Bao Wang· 2025-06-11 14:09
*ST金比(002762)控制权变更事项迎来新进展。6月11日晚,*ST金比公告,自6月12日开市起复牌。 *ST金比此前公告,公司收到控股股东、实际控制人林浩亮、林若文的通知,获悉其正在筹划公司股份 协议转让事宜,拟通过向交易对手方转让公司股份等方式,使交易对手方获得公司控制权,具体转让比 例和实施方案尚待进一步沟通确定。若本次交易完成,公司的控股股东、实际控制人将发生变更。 6月11日晚,*ST金比披露,林浩亮、林若文与上海元一成物科技有限公司(以下简称"元一成物")签署了 《股份转让协议》。林浩亮和林若文拟合计向元一成物转让股份4708.5万股,占公司总股本的13.30%。 此次股份转让价格为7.34元/股,高于*ST金比最近一个交易日6月4日6.16元/股的收盘价,此次转让价款 总计3.46亿元。 与此同时,林浩亮和林若文与元一成物签署了《表决权放弃协议》。根据《表决权放弃协议》的约定, 林浩亮和林若文同意无条件且不可撤销地放弃其所持上述转让股份以外剩余股份对应的表决权。 此次转让完成后,元一成物将持有上市公司13.30%的股份,其实际控制人陈珂如将成为上市公司实际 控制人。*ST金比改组董事会,元一 ...
*ST金比: 关于控股股东、实际控制人签署《股份转让协议》《表决权放弃协议》暨公司控制权拟发生变更的提示性公告
Zheng Quan Zhi Xing· 2025-06-11 13:20
Core Viewpoint - The announcement details a significant change in control for Jinfa Labi Maternal and Child Products Co., Ltd, with Yuan Yi Cheng Wu becoming the controlling shareholder and Chen Keru as the actual controller, following the signing of a share transfer agreement and a voting rights waiver agreement [1][20]. Summary of Key Points 1. Basic Situation of the Equity Change - Lin Haoliang and Lin Ruowen plan to transfer a total of 47,085,325 shares, representing 13.30% of the company's total share capital, to Yuan Yi Cheng Wu at a price of 7.34 CNY per share, totaling approximately 345.61 million CNY [2][5]. - Following the transfer, Lin Haoliang and Lin Ruowen will waive their voting rights for the remaining shares they hold, which amounts to 20.48% and 19.47% of the total shares, respectively [2][18]. 2. Details of the Share Transfer Agreement - The first share transfer involves Lin Haoliang transferring 24,134,838 shares (6.82%) and Lin Ruowen transferring 22,950,487 shares (6.48%) [5][19]. - The agreement stipulates that if any dividends or capital increases occur before the transfer is completed, the share price and quantity will be adjusted accordingly, but the total transfer price remains unchanged [6][8]. 3. Governance Arrangements - After the completion of the first share transfer, Yuan Yi Cheng Wu will have the right to nominate four directors to the board, ensuring they hold a majority [11][12]. - The board will consist of seven members, with the new directors being a mix of independent and non-independent candidates [11][12]. 4. Impact of the Equity Change - The change in control is not expected to adversely affect the company's normal operations or harm the interests of minority shareholders [20]. - Yuan Yi Cheng Wu currently has no plans to inject assets into the company following the transfer [20]. 5. Compliance and Future Steps - The share transfer is subject to compliance review by the Shenzhen Stock Exchange and must be registered with the China Securities Depository and Clearing Corporation [20][21]. - The completion of the transaction is uncertain and may be subject to significant risks that could lead to its termination [20][21].
*ST金比(002762.SZ):控股股东将变更为元一成物、实控人将变更为陈珂如 6月12日起复牌


Ge Long Hui A P P· 2025-06-11 13:05
格隆汇6月11日丨*ST金比(002762.SZ)公布,2025年6月11日,公司控股股东、实际控制人林浩亮先生 (简称"甲方一")、林若文女士(简称"甲方二")与元一成物(即"乙方")签署了《股份转让协议》。林浩亮先 生拟向元一成物转让其持有的公司无限售条件流通股24,134,838股,占公司总股本的6.82%;林若文女 士拟向元一成物转让其持有的公司无限售条件流通股22,950,487股,占公司总股本的6.48%。林浩亮先 生和林若文女士本次合计转让股份47,085,325股,占公司总股本的13.30%(以下称"第一次股份转让标的 股份")。本次股份转让价格为7.34元/股,转让价款合计为人民币3.456亿元。 同日,林浩亮先生和林若文女士与元一成物签署了《表决权放弃协议》。根据《表决权放弃协议》的约 定,甲方一同意无条件且不可撤销地放弃其所持除第一次股份转让标的股份以外剩余的72,494,061股股 份(占上市公司股份总数的20.48%)所对应的表决权;甲方二同意无条件且不可撤销地放弃其所持除第一 次股份转让标的股份以外剩余的68,936,611股股份(占上市公司股份总数的19.47%)所对应的表决权。 ...
*ST金比(002762) - 关于控股股东、实际控制人签署《股份转让协议》《表决权放弃协议》暨公司控制权拟发生变更的提示性公告
2025-06-11 12:48
证券代码:002762 证券简称:*ST金比 公告编号:2025-031号 特别提示: 金发拉比妇婴童用品股份有限公司 关于控股股东、实际控制人签署《股份转让协议》、 《表决权放弃协议》暨公司控制权拟发生变更的 提示性公告 1、本次股份转让事项尚需经上海元一成物科技有限公司(以下简称"元一 成物")对金发拉比妇婴童用品股份有限公司(以下简称"公司"或"上市公司") 进行尽职调查,尚需提交深圳证券交易所进行合规性审核,并在中国证券登记结 算有限责任公司深圳分公司办理股份协议转让过户相关手续。上述事项的完成情 况将影响本次交易的进行,若过程中出现影响本次交易的重大风险,则本次交易 可能存在终止的风险。本次交易事项能否最终实施完成及实施结果尚存在重大不 确定性,公司将根据后续进展情况,及时履行相关信息披露义务。敬请广大投资 者理性分析、谨慎决策、注意投资风险。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或者重大遗漏。 2、若本次股份转让事项实施并完成,公司的控股股东及实际控制人将发生 变更。元一成物将成为公司的控股股东,陈珂如女士将成为公司的实际控制人, 目前元一成物暂无向 ...
*ST金比(002762) - 关于筹划公司控制权变更事项的进展暨复牌公告
2025-06-11 12:46
1、金发拉比妇婴童用品股份有限公司(以下简称"公司")股票(证券简称: *ST 金比,股票代码:002762)自 2025 年 6 月 12 日(星期四)开市起复牌。 2、本次交易事项能否最终实施完成及实施结果尚存在重大不确定性,敬请 广大投资者注意投资风险。 一、停牌事项 公司此前收到控股股东、实际控制人林浩亮先生、林若文女士的通知,获悉 其正在筹划公司股份协议转让事宜,拟通过向交易对手方转让公司股份等方式, 使交易对手方获得公司控制权,具体转让比例和实施方案尚待进一步沟通确定。 若本次交易完成,公司的控股股东、实际控制人将发生变更。 鉴于上述事项尚存在重大不确定性,为保证公平信息披露,维护投资者利益, 避免造成公司股价异常波动,根据《深圳证券交易所股票上市规则》、《深圳证券 交易所上市公司自律监管指引第 6 号——停复牌》等有关规定,经公司向深圳证 券交易所申请,公司股票(股票简称:*ST 金比,股票代码:002762)自 2025 年 6 月 5 日(星期四)上午开市起停牌。具体内容请详见公司于 2025 年 6 月 5 日、2025 年 6 月 9 日刊登在《中国证券报》、《证券时报》、《上海证券报》 ...
财达证券晨会纪要-20250610
Caida Securities· 2025-06-10 03:08
Summary of Key Points Group 1: Market Activity - The report highlights the listing of Huazhi Jie (603400) on June 10, 2025, with online subscription available on the same day [1] - Several ETFs, including Guolian Zhongzheng A50 ETF (159390), Invesco S&P Consumer Select ETF (159529), and Guotai S&P 500 ETF (159612), announced temporary suspensions for investor protection on June 10, 2025 [1] - The report notes the suspension of various bonds and securities, including *ST Zhongdi (000609) and *ST Gongzhi (000584), due to risk warnings and potential delisting [2][3] Group 2: Special Suspensions - The report details multiple companies facing special suspensions, such as *ST Hengli (000622) and Tianmao Group (000627), due to failure to disclose periodic reports within the legal timeframe [2] - Other companies, including *ST Jinbi (002762) and Honghe Technology (002955), are suspended due to control change planning [2] - A list of various bonds and securities that have been suspended since 2018 is provided, indicating ongoing market volatility and regulatory scrutiny [3][4] Group 3: Ongoing Monitoring - The report emphasizes the importance of monitoring the status of suspended securities, as many have been inactive for extended periods, indicating potential long-term issues within those companies [5][6] - The report suggests that investors should remain vigilant regarding the performance and announcements related to these suspended entities, as they may present future investment opportunities or risks [7][8]
*ST金比(002762) - 关于筹划公司控制权变更事项进展暨继续停牌的公告
2025-06-08 07:45
特别提示: 证券代码:002762 证券简称:*ST金比 公告编号:2025-029号 金发拉比妇婴童用品股份有限公司 关于筹划公司控制权变更事项进展暨继续停牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 二、进展情况 截至本公告披露之日,交易各方正在对本次控制权变更的具体方案进行友好协商 洽谈,各方尚未签署有关协议,公司股票预计无法在 2025 年 6 月 9 日(星期一)开市 起复牌。根据《深圳证券交易所股票上市规则》、《深圳证券交易所上市公司自律监 管指引第 6 号——停复牌》等有关规定,经公司向深圳证券交易所申请,公司股票 (股票简称:*ST 金比,股票代码:002762)自 2025 年 6 月 9 日(星期一)开市起继 续停牌,预计停牌时间不超过 3 个交易日。 股票停牌期间,公司将根据上述交易事项进展情况,严格按照有关法律法规的规 定履行信息披露义务。待该事项确定后,公司将及时发布相关公告并申请公司股票复 牌。公司指定信息披露媒体为《中国证券报》、《证券时报》、《上海证券报》及巨 潮资讯网(http://www.cninfo.com.c ...
退市风险下实控人拟转让股份 *ST金比控制权或将变动
Zheng Quan Ri Bao· 2025-06-05 14:42
Core Viewpoint - The company *ST Jinbi is undergoing a potential change in control, with its major shareholders planning to transfer shares, which introduces both hope and uncertainty for the company's future [2][3][6] Group 1: Control Change Announcement - On June 5, *ST Jinbi announced a suspension of trading due to plans for a change in control, with the suspension expected to last no more than two trading days [2] - The change in control is currently in the negotiation stage, and there is significant uncertainty surrounding the outcome [3] Group 2: Shareholding Structure - As of the end of Q1 2025, the major shareholders Lin Haoliang and Lin Ruowen hold 27.29% and 25.95% of the shares respectively, totaling 53.24%, while the third-largest shareholder holds only 0.57% [3] Group 3: Business Overview - *ST Jinbi operates in the maternal and infant consumer goods sector, managing three proprietary brands: LABI BABY, I LOVE BABY, and BABY LABI [3] - The company has faced significant pressure on its performance due to increasing competition in the maternal and infant market [3] Group 4: Financial Performance - Since 2019, *ST Jinbi's revenue has declined from 438 million to 225 million in 2024, with net profits showing losses for three consecutive years from 2022 to 2024 [4] - The company has been under risk warning for delisting due to financial performance issues, as it met criteria for negative profit and revenue thresholds [4] Group 5: Strategic Moves - To mitigate delisting risks, *ST Jinbi has attempted to enter the medical beauty industry, acquiring stakes in Guangdong Hanfei Hospital Investment Co., Ltd. in 2021 and 2023 [5] - In 2025, the company consolidated its medical beauty operations by integrating subsidiaries, but the impact on financial performance has been limited, with a reported revenue of 76.06 million in Q1 2025, a 74.85% increase year-on-year, yet still showing a net loss [5][6]